Truist reiterates American Express stock rating on spending momentum By Investing.com

Truist lowered its AXP price target to $360 from $400 but maintained a Buy and raised its 2026 EPS estimate to $18.00 (+1%). AXP shares are down 19.4% YTD, trading at $299.59, yet Truist’s proprietary card-spend data shows modest acceleration into March with travel & leisure strength—potential upside to billed business and a near-term catalyst. American Express also announced a multi-year NFL payments partnership beginning 2026 and launched the Graphite Business Cash Unlimited Card (2% unlimited cash back; 5% on flights/prepaid hotels via AmEx Travel; $295 annual fee) and plans eight new/enhanced business products in 2026.

Analysis

Thesis: The durable premium-spend cohort that a closed-loop card can reach gives the issuer structural pricing power on interchange and lending margins, but the path to realizing that power is execution-dependent — unit economics will hinge on activation costs for high-fee products and the marginal yield on revolving balances. If new premium products and experiential partnerships scale without proportionally higher acquisition costs, EPS leverage could be meaningful over 12–24 months; conversely, poor take-up or elevated churn would compress returns quickly because fixed marketing and rewards investments are front-loaded.

Winners and losers: Beyond the issuer itself, global travel vendors (hotel groups, premium airlines) and specialist loyalty/CRM vendors are likely to win incremental direct-booking flows and higher spend per customer as premium-card perks shift demand toward partners that pay higher placement fees. Incumbent network operators face a nuanced dynamic — closed-loop rewards can insulate a premium issuer versus raw volume competition, but reduced cross-network interchange growth could slow network fee accretion; BNPL and low-fee fintechs are the natural marginal losers if affluent cohorts consolidate spend under premium cards.

Risks & catalysts: The immediate catalyst window is the upcoming quarterly prints and subsequent guidance revisions (days–weeks), with medium-term catalysts at 6–18 months as new product cohorts and partnership monetization materialize. Tail risks include a macro shock that curtails travel (reversing yield assumptions), regulatory actions on merchant fees, and credit deterioration that raises loss provisions; these can flip the story within a single quarter and warrant tight P&L monitoring.

Contrarian view: Consensus valuation appears to bake in either weak monetization of new products or rising credit costs; that opens an asymmetric payoff if premium cohorts sustain spend and incremental ROIC exceeds acquisition costs. The read-through is not binary — stewardship of funding costs and smart tiering of benefits will determine whether this issuer re-rates to a premium multiple or underperforms peers.

Key Decisions for Investors

• Long AXP equity (size 1–2% NAV) ahead of next quarterly results, scale into sustained strength; set a 12–18 month target return of +30% and a tactical stop-loss at -15% from entry to limit drawdown on a downside print.
• Buy AXP 12–18 month call spread (approx. 25–35% OTM) sized so max premium = 0.5–1% NAV — asymmetric downside (limited premium) vs 2–4x upside if monetization/re-rate occurs; roll or take profits at 50–75% of max profit.
• Pair trade: Long AXP / Short V (equal notional) over 6–12 months to play premium-card re-rating vs broad network multiple compression; monitor cross-border volumes and interchange regulation as stop triggers (unwind if macro-driven global volume collapse >8% QoQ).
• Event hedge: Buy 3–6 month out-of-the-money AXP put protection (~7–12% OTM) if entering or adding to long exposure prior to earnings to cap 1–quarter downside from a negative surprise (cost should be <1% NAV for tactical protection).